QSS
IMMU

Quantitative Systematic Strategies’s Immunomedics Inc IMMU Stock Holding History

Quantitative Systematic Strategies’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,697
Closed -$698K – 775
2020
Q2 		$698K Sell
19,697
-6,205
-24% -$181K 0.14% 242
2020
Q1 		$349K Buy
25,902
+286
+1% +$4.81K 0.29% 129
2019
Q4 		$542K Buy
25,616
+1,745
+7% +$30.8K 0.08% 318
2019
Q3 		$317K Buy
+23,871
New +$351K 0.07% 325
2019
Q1 		– Sell
-11,031
Closed -$157K – 750
2018
Q4 		$157K Sell
11,031
-1,619
-13% -$32.1K 0.04% 563
2018
Q3 		$263K Buy
+12,650
New +$300K 0.05% 451
2018
Q2 		– Sell
-12,296
Closed -$180K – 848
2018
Q1 		$180K Buy
+12,296
New +$201K 0.04% 574
2017
Q4 		– Sell
-10,192
Closed -$142K – 696
2017
Q3 		$142K Sell
10,192
-3,211
-24% -$32K 0.04% 416
2017
Q2 		$117K Sell
13,403
-7,771
-37% -$54.6K 0.03% 419
2017
Q1 		$137K Buy
+21,174
New +$107K 0.04% 341
2016
Q3 		– Sell
-217,000
Closed -$497K – 548
2016
Q2 		$497K Buy
+217,000
New +$725K 0.23% 183

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Quantitative Systematic Strategies's IMMU Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 19,697 shares — an estimated $698K sold.

Quantitative Systematic Strategies first reported a position in IMMU in Q2 2016 and held it in 11 quarters. The position peaked at $698K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Quantitative Systematic Strategies reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 19,697 Immunomedics Inc shares in Q3 2020, an estimated $698K.
  • Quantitative Systematic Strategies first reported a position in Immunomedics Inc in Q2 2016 and held it in 11 quarters.
  • Quantitative Systematic Strategies's Immunomedics Inc position peaked at $698K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.